Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lenapharm is a Greek pharmaceutical company headquartered in Athens, specializing in the marketing, distribution, and development of pharmaceutical products, medical devices, and food supplements. Established in 2005, the company has built a robust portfolio of generic medications focusing on key therapeutic areas such as cardiology, neurology, and respiratory medicine. Lenapharm operates primarily within the Greek healthcare market, providing cost-effective treatment options to hospitals and pharmacies. The company maintains strategic partnerships with international manufacturers to ensure a steady supply of high-quality healthcare solutions. Its business model combines pharmaceutical expertise with a strong distribution network to improve patient access to essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lenapharm.